Sanofi's $638m plant in Singapore will be able to produce up to 4 types of vaccines simultaneously

Sanofi's $638m plant in Singapore will be able to produce up to 4 types of vaccines simultaneouslyПодробнее

Sanofi's new vaccine facility in Singapore to ramp up production for Asia | THE BIG STORYПодробнее

Sanofi's SVP speaks about setting up vaccine production site in SingaporeПодробнее

Sanofi halts development of its Covid mRNA vaccineПодробнее

Canada, Ontario inject millions in future Sanofi plant to strengthen vaccine manufacturing | FULLПодробнее

Sanofi to help produce doses of Pfizer-BioNTech Covid vaccineПодробнее

Hilleman Laboratories' new S$80m vaccine manufacturing plant to be fully operational by early 2023Подробнее

Our Evolutive Vaccine Facility in SingaporeПодробнее

Sanofi invests S$638m in vaccine production facility in SingaporeПодробнее

Sanofi: Our vaccine could serve as an excellent booster shotПодробнее

SIU Medicine | Boost Campaign III 2023Подробнее

COVID-19: Singapore to accelerate its vaccination programmeПодробнее

Sanofi and GSK see positive interim results for their Covid vaccine in trialsПодробнее

COVID-19: Private clinics in Singapore will be allowed to use and administer WHO-approved vaccinesПодробнее

Experts Explain - Vaccine Approval Process by Health Sciences Authority (HSA)Подробнее

Sanofi drops vaccine bid amid rivals' successПодробнее

UK Seeks to Purchase 6.3 Million RSV Vaccines for Babies, ElderlyПодробнее

Sanofi – Making VaccinesПодробнее

Sanofi Has Two Covid Vaccines in Clinical TrialsПодробнее

The A - Z of the Covid-19 vaccineПодробнее